1. 1. A plan is established, documented, and implemented for an ongoing quality management program that, at a minimum, includes:

   1. a. A method to identify, document, and evaluate opioid-related adverse reactions or other incidents;
   2. b. A method to collect data on services provided to patients;
   3. c. A method to use the data to identify concerns about the delivery of services related to patient care;
   4. d. A method to make changes or take action in response to a concern identified according to subsection (1)(c); and
   5. e. The frequency with which the documented report required in subsection (2) will be submitted to the licensee;

2. 2. A documented report is submitted to the licensee that includes:

   1. a. Each concern about the delivery of services related to patient care, and
   2. b. Any changes made or actions taken in response to that concern; and
3. 3. The report required in subsection (2) and the supporting documentation for the report are maintained for at least 12 months after the date the report is submitted to the licensee.

A medical director shall ensure that:

Historical Note

New Section made by final rulemaking at 24 A.A.R. 3020, effective January 1, 2019 (Supp. 18-4).